Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 237

1.

Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute.

Müller C, De Prado Leal M, Dominietto MD, Umbricht CA, Safai S, Perrin RL, Egloff M, Bernhardt P, van der Meulen NP, Weber DC, Schibli R, Lomax AJ.

Pharmaceutics. 2019 Sep 2;11(9). pii: E450. doi: 10.3390/pharmaceutics11090450.

2.

In Reply to Dr Bennett.

McIntosh SE, Hemphill M, McDevitt MC, Gurung TY, Ghale M, Knott JR, Thapa GB, Basnyat B, Dow J, Weber DC, Grissom CK.

Wilderness Environ Med. 2019 Sep;30(3):334-335. doi: 10.1016/j.wem.2019.06.010. Epub 2019 Aug 8. No abstract available.

PMID:
31402098
3.

Daily adaptive proton therapy - the key to innovative planning approaches for paranasal cancer treatments.

Nenoff L, Matter M, Hedlund Lindmar J, Weber DC, Lomax AJ, Albertini F.

Acta Oncol. 2019 Jul 31:1-6. doi: 10.1080/0284186X.2019.1641217. [Epub ahead of print]

4.

Radiation-induced optic neuropathy after pencil beam scanning proton therapy for skull-base and head and neck tumours.

Kountouri M, Pica A, Walser M, Albertini F, Bolsi A, Kliebsch U, Bachtiary B, Combescure C, Lomax AJ, Schneider R, Weber DC.

Br J Radiol. 2019 Aug 1:20190028. doi: 10.1259/bjr.20190028. [Epub ahead of print]

PMID:
31322969
5.

Intensity modulated proton therapy plan generation in under ten seconds.

Matter M, Nenoff L, Meier G, Weber DC, Lomax AJ, Albertini F.

Acta Oncol. 2019 Jul 4:1-5. doi: 10.1080/0284186X.2019.1630753. [Epub ahead of print]

6.

Results of a multicentre dosimetry audit using a respiratory phantom within the EORTC LungTech trial.

Lambrecht ML, Eaton DJ, Sonke JJ, Nestle U, Peulen H, Weber DC, Verheij M, Hurkmans CW.

Radiother Oncol. 2019 Sep;138:106-113. doi: 10.1016/j.radonc.2019.06.008. Epub 2019 Jun 25.

PMID:
31252291
7.

Bringing Europe together in building clinical evidence for proton therapy - the EPTN-ESTRO-EORTC endeavor.

Weber DC, Grau C, Lim PS, Georg D, Lievens Y.

Acta Oncol. 2019 Jun 26:1-3. doi: 10.1080/0284186X.2019.1624820. [Epub ahead of print] No abstract available.

PMID:
31241391
8.

Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates.

van de Water S, Safai S, Schippers JM, Weber DC, Lomax AJ.

Acta Oncol. 2019 Jun 26:1-7. doi: 10.1080/0284186X.2019.1627416. [Epub ahead of print]

PMID:
31241377
9.

Proton therapy for brain tumours in the area of evidence-based medicine.

Weber DC, Lim PS, Tran S, Walser M, Bolsi A, Kliebsch U, Beer J, Bachtiary B, Lomax T, Pica A.

Br J Radiol. 2019 May 20:20190237. doi: 10.1259/bjr.20190237. [Epub ahead of print]

PMID:
31067074
10.

Dosimetric uncertainties as a result of temporal resolution in 4D dose calculations for PBS proton therapy.

Zhang Y, Huth I, Weber DC, Lomax AJ.

Phys Med Biol. 2019 Jun 13;64(12):125005. doi: 10.1088/1361-6560/ab1d6f.

PMID:
31035271
11.

The dosimetric effect of residual breath-hold motion in pencil beam scanned proton therapy - An experimental study.

Gorgisyan J, Lomax AJ, Rosenschold PMA, Persson GF, Krieger M, Colvill E, Scherman J, Gagnon-Moisan F, Egloff M, Fattori G, Engelholm SA, Weber DC, Perrin R.

Radiother Oncol. 2019 May;134:135-142. doi: 10.1016/j.radonc.2019.01.033. Epub 2019 Feb 14.

PMID:
31005207
12.

Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomas.

Tran S, Puric E, Walser M, Poel R, Datta NR, Heuberger J, Pica A, Marder D, Lomax N, Bolsi A, Morach P, Bachtiary B, Seddon BM, Schneider R, Bodis S, Weber DC.

Br J Radiol. 2019 May 14:20180883. doi: 10.1259/bjr.20180883. [Epub ahead of print]

PMID:
30943055
13.

[Rhabdoid Tumour of the Orbit in a Child].

Wilms V, Jäger M, Schlamann M, Weber DC, Lorenz B.

Klin Monbl Augenheilkd. 2019 Apr 2. doi: 10.1055/a-0838-5604. [Epub ahead of print] German. No abstract available.

PMID:
30939620
14.

Comparison of supine or prone crawl photon or proton breast and regional lymph node radiation therapy including the internal mammary chain.

Speleers BA, Belosi FM, De Gersem WR, Deseyne PR, Paelinck LM, Bolsi A, Lomax AJ, Boute BG, Van Greveling AE, Monten CM, Van de Velde JJ, Vercauteren TH, Veldeman L, Weber DC, De Neve WC.

Sci Rep. 2019 Mar 18;9(1):4755. doi: 10.1038/s41598-019-41283-1.

15.

The dependence of interplay effects on the field scan direction in PBS proton therapy.

Fattori G, Klimpki G, Hrbacek J, Zhang Y, Krieger M, Placidi L, Psoroulas S, Weber DC, Lomax AJ, Safai S.

Phys Med Biol. 2019 Apr 23;64(9):095005. doi: 10.1088/1361-6560/ab1150.

PMID:
30893664
16.

Comparing the effectiveness and efficiency of various gating approaches for PBS proton therapy of pancreatic cancer using 4D-MRI datasets.

Dolde K, Naumann P, Dávid C, Kachelriess M, Lomax AJ, Weber DC, Saito N, Burigo LN, Pfaffenberger A, Zhang Y.

Phys Med Biol. 2019 Apr 10;64(8):085011. doi: 10.1088/1361-6560/ab1175.

PMID:
30893660
17.

Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results.

Lambrecht M, Clementel E, Sonke JJ, Nestle U, Adebahr S, Guckenberger M, Andratschke N, Weber DC, Verheij M, Hurkmans CW.

Radiother Oncol. 2019 Mar;132:63-69. doi: 10.1016/j.radonc.2018.10.025. Epub 2018 Dec 21.

PMID:
30825971
18.

Whole-ventricular irradiation for intracranial germ cell tumors: Dosimetric comparison of pencil beam scanned protons, intensity-modulated radiotherapy and volumetric-modulated arc therapy.

Correia D, Terribilini D, Zepter S, Pica A, Bizzocchi N, Volken W, Stieb S, Ahlhelm F, Herrmann E, Fix MK, Manser P, Aebersold DM, Weber DC.

Clin Transl Radiat Oncol. 2019 Jan 9;15:53-61. doi: 10.1016/j.ctro.2019.01.002. eCollection 2019 Feb.

19.

4DMRI-based investigation on the interplay effect for pencil beam scanning proton therapy of pancreatic cancer patients.

Dolde K, Zhang Y, Chaudhri N, Dávid C, Kachelrieß M, Lomax AJ, Naumann P, Saito N, Weber DC, Pfaffenberger A.

Radiat Oncol. 2019 Feb 7;14(1):30. doi: 10.1186/s13014-019-1231-2.

20.

Author Correction: An IDS-Type Sesquiterpene Synthase Produces the Pheromone Precursor (Z)-α-Bisabolene in Nezara viridula.

Lancaster J, Lehner B, Khrimian A, Muchlinski A, Luck K, Köllner TG, Weber DC, Gundersen-Rindal DE, Tholl D.

J Chem Ecol. 2019 Feb;45(2):198. doi: 10.1007/s10886-019-01049-5.

PMID:
30710237

Supplemental Content

Loading ...
Support Center